-
1
-
-
0025893945
-
Parkinson's disease: Pathophysiology
-
Agid Y (1991) Parkinson's disease: pathophysiology. Lancet 337:1321-1324.
-
(1991)
Lancet
, vol.337
, pp. 1321-1324
-
-
Agid, Y.1
-
2
-
-
0035353725
-
Frequency of levodoparelated dyskinesia and motor fluctuations as estimated from the cumulative literature
-
Ahlskog JE, Munenter MD (2001) Frequency of levodoparelated dyskinesia and motor fluctuations as estimated from the cumulative literature. Mov Disord 16: 448-458.
-
(2001)
Mov Disord
, vol.16
, pp. 448-458
-
-
Ahlskog, J.E.1
Munenter, M.D.2
-
3
-
-
0030450402
-
A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases
-
14014-14009
-
Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. PNAS 93: 14014-14009.
-
(1996)
PNAS
, vol.93
-
-
Amin, A.R.1
Attur, M.G.2
Thakker, G.D.3
Patel, P.D.4
Vyas, P.R.5
Patel, R.N.6
Patel, I.R.7
Abramson, S.B.8
-
4
-
-
0031036896
-
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
-
Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch MT, Aged Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12: 25-31.
-
(1997)
Histol Histopathol
, vol.12
, pp. 25-31
-
-
Anglade, P.1
Vyas, S.2
Javoy-Agid, F.3
Herrero, M.T.4
Michel, P.P.5
Marquez, J.6
Mouatt-Prigent, A.7
Ruberg, M.8
Hirsch, M.T.9
Aged, Y.10
-
5
-
-
0031661173
-
Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice
-
Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71: 1635-1642.
-
(1998)
J Neurochem
, vol.71
, pp. 1635-1642
-
-
Aubin, N.1
Curet, O.2
Deffois, A.3
Carter, C.4
-
6
-
-
0038051345
-
Mitochondria, oxidative damage, and inflammation in Parkinson's disease
-
Beal MF (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann NY Acad Sci 991: 120-131.
-
(2003)
Ann NY Acad Sci
, vol.991
, pp. 120-131
-
-
Beal, M.F.1
-
7
-
-
0021997074
-
Poly (ADP-ribose) in the cellular response to DNA damage
-
Berger NA (1985) Poly (ADP-ribose) in the cellular response to DNA damage. Radiat Res 101: 4-15.
-
(1985)
Radiat Res
, vol.101
, pp. 4-15
-
-
Berger, N.A.1
-
8
-
-
0034672304
-
Towards a neuroprotective gene therapy for Parkinson's disease: Use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
-
Bjorklund S, Bocciardi R, Bonardi G, Matera I, Santamaria G, Mandel RJ (2000) Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res 886: 82-98.
-
(2000)
Brain Res
, vol.886
, pp. 82-98
-
-
Bjorklund, S.1
Bocciardi, R.2
Bonardi, G.3
Matera, I.4
Santamaria, G.5
Mandel, R.J.6
-
9
-
-
0034993599
-
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease
-
Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65: 135-172.
-
(2001)
Prog Neurobiol
, vol.65
, pp. 135-172
-
-
Blum, D.1
Torch, S.2
Lambeng, N.3
Nissou, M.4
Benabid, A.L.5
Sadoul, R.6
Verna, J.M.7
-
10
-
-
0030938169
-
The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-Bcatalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Castagnoli K, Palmer S, Anderson A, Bueters T, Castagnoli N Jr (1997) The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-Bcatalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chem Res Toxicol 10: 364-368.
-
(1997)
Chem Res Toxicol
, vol.10
, pp. 364-368
-
-
Castagnoli, K.1
Palmer, S.2
Anderson, A.3
Bueters, T.4
Castagnoli Jr., N.5
-
11
-
-
4744369832
-
Upregulation of expression and activity guanylyl cyclase in MPTP animals model Parkinson's disease
-
Chalimoniuk M, Langfort J, Lukacova N, Marsala J (2004) Upregulation of expression and activity guanylyl cyclase in MPTP animals model Parkinson's disease. Biochem Biophys Res Commun 324: 118-126.
-
(2004)
Biochem Biophys Res Commun
, vol.324
, pp. 118-126
-
-
Chalimoniuk, M.1
Langfort, J.2
Lukacova, N.3
Marsala, J.4
-
12
-
-
33745991786
-
Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in mouse
-
Chalimoniuk M, Lukacova N, Marsala J, Langfort J (2006) Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in mouse. Neuroscience 141: 1033-1046.
-
(2006)
Neuroscience
, vol.141
, pp. 1033-1046
-
-
Chalimoniuk, M.1
Lukacova, N.2
Marsala, J.3
Langfort, J.4
-
13
-
-
34248201158
-
The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice
-
Chalimoniuk M, Langfort J (2007) The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem Int 50: 821-833.
-
(2007)
Neurochem Int
, vol.50
, pp. 821-833
-
-
Chalimoniuk, M.1
Langfort, J.2
-
14
-
-
2942642117
-
Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetraphdropyridine-treated mice
-
Chen LW, Hu HJ, Liu HL, Yung KK, Chan YS (2004) Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetraphdropyridine-treated mice. Neuroscience 126: 941-953.
-
(2004)
Neuroscience
, vol.126
, pp. 941-953
-
-
Chen, L.W.1
Hu, H.J.2
Liu, H.L.3
Yung, K.K.4
Chan, Y.S.5
-
15
-
-
0032563356
-
Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced neurotoxicity in C57BL/6 mice
-
Cheng FC, Ni DR, Wu MC, Kuo JS, Chia LG (1998) Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced neurotoxicity in C57BL/6 mice. Neurosci Lett 252: 87-90.
-
(1998)
Neurosci Lett
, vol.252
, pp. 87-90
-
-
Cheng, F.C.1
Ni, D.R.2
Wu, M.C.3
Kuo, J.S.4
Chia, L.G.5
-
16
-
-
0030581308
-
Poly (ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice
-
Cosi C, Colpaert F, Koek W, Degryse A, Marien M (1996) Poly (ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice. Brain Res 729: 264-269.
-
(1996)
Brain Res
, vol.729
, pp. 264-269
-
-
Cosi, C.1
Colpaert, F.2
Koek, W.3
Degryse, A.4
Marien, M.5
-
17
-
-
0032569674
-
+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Prevention by the poly (ADPribose) polymerase inhibitor, benzamide
-
+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly (ADPribose) polymerase inhibitor, benzamide. Brain Res 809: 58-67.
-
(1998)
Brain Res
, vol.809
, pp. 58-67
-
-
Cosi, C.1
Marien, M.2
-
18
-
-
0032514206
-
GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice
-
Date I, Aoi M, Tomita S, Collins F, Ohtomo T (1998) GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice. Neuroreport 9: 2365-2369.
-
(1998)
Neuroreport
, vol.9
, pp. 2365-2369
-
-
Date, I.1
Aoi, M.2
Tomita, S.3
Collins, F.4
Ohtomo, T.5
-
19
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
20
-
-
0034006478
-
Deficiency of inducible nitric oxide synthase protects against MPTP neurotoxicity in vivo
-
Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB (2000) Deficiency of inducible nitric oxide synthase protects against MPTP neurotoxicity in vivo. J Neurochem 74: 2213-2216.
-
(2000)
J Neurochem
, vol.74
, pp. 2213-2216
-
-
Dehmer, T.1
Lindenau, J.2
Haid, S.3
Dichgans, J.4
Schulz, J.B.5
-
21
-
-
3042755065
-
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
-
Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F (2004) Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19: 3266-3276.
-
(2004)
Eur J Neurosci
, vol.19
, pp. 3266-3276
-
-
Diguet, E.1
Fernagut, P.O.2
Wei, X.3
Du, Y.4
Rouland, R.5
Gross, C.6
Bezard, E.7
Tison, F.8
-
22
-
-
0030842946
-
Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
-
Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VL (1997) Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089-1095.
-
(1997)
Nat Med
, vol.3
, pp. 1089-1095
-
-
Eliasson, M.J.1
Sampei, K.2
Mandir, A.S.3
Hurn, P.D.4
Traystman, R.J.5
Bao, J.6
Pieper, A.7
Wang, Z.Q.8
Dawson, T.M.9
Snyder, S.H.10
Dawson, V.L.11
-
23
-
-
0030832874
-
Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase
-
Endres M, Wang Q, Namura S, Waeber C, Moskowitz, MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17: 1143-1151.
-
(1997)
J Cereb Blood Flow Metab
, vol.17
, pp. 1143-1151
-
-
Endres, M.1
Wang, Q.2
Namura, S.3
Waeber, C.4
Moskowitz, M.A.5
-
24
-
-
0032555154
-
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
-
Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. PNAS 95: 8880-8885.
-
(1998)
PNAS
, vol.95
, pp. 8880-8885
-
-
Endres, M.1
Laufs, U.2
Huang, Z.3
Nakamura, T.4
Huang, P.5
Moskowitz, M.A.6
Liao, J.K.7
-
25
-
-
0032506608
-
Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease
-
Eve DJ, Nisbet AP, Kingsbury AE, Hewson EL, Daniel SE, Lees AJ, Marsden CD, Forster OJ (1998) Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Mol Brain Res 63: 62-71.
-
(1998)
Mol Brain Res
, vol.63
, pp. 62-71
-
-
Eve, D.J.1
Nisbet, A.P.2
Kingsbury, A.E.3
Hewson, E.L.4
Daniel, S.E.5
Lees, A.J.6
Marsden, C.D.7
Forster, O.J.8
-
26
-
-
0028276809
-
Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinum toxicity to dopaminergic neurons in the rat
-
Frim DM, Uhler TA, Galpem WR, Beal MF, Breakefield XO, Isacson O (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinum toxicity to dopaminergic neurons in the rat. PNAS 9: 5104-5108.
-
(1994)
PNAS
, vol.9
, pp. 5104-5108
-
-
Frim, D.M.1
Uhler, T.A.2
Galpem, W.R.3
Beal, M.F.4
Breakefield, X.O.5
Isacson, O.6
-
27
-
-
0005934486
-
Neurotrophic factors in neurodegenerative disorders: Model of Parkinson's disease
-
Garcia de Yebenes J, Yebenes J, Mena MA (2000) Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease. Neurotox Res 2: 115-137.
-
(2000)
Neurotox Res
, vol.2
, pp. 115-137
-
-
de Garcia Yebenes, J.1
Yebenes, J.2
Mena, M.A.3
-
28
-
-
0033792866
-
Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease
-
Gatto EM, Riobo NA, Carreras MC, Chernavsky A, Rubio A, Satz ML, Poderoso JJ (2000) Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease. Nitric Oxide 4: 534-539.
-
(2000)
Nitric Oxide
, vol.4
, pp. 534-539
-
-
Gatto, E.M.1
Riobo, N.A.2
Carreras, M.C.3
Chernavsky, A.4
Rubio, A.5
Satz, M.L.6
Poderoso, J.J.7
-
29
-
-
0024434128
-
Midbrain dopaminergic cell loss in Parkinson's disease: Computer visualization
-
German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26: 507-514.
-
(1989)
Ann Neurol
, vol.26
, pp. 507-514
-
-
German, D.C.1
Manaye, K.2
Smith, W.K.3
Woodward, D.J.4
Saper, C.B.5
-
30
-
-
0038249170
-
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson's disease
-
Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendesen CN, Heywood P (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson's disease. Nat Med 9: 589-595.
-
(2003)
Nat Med
, vol.9
, pp. 589-595
-
-
Gill, S.S.1
Patel, N.K.2
Hotton, G.R.3
O'Sullivan, K.4
McCarter, R.5
Bunnage, M.6
Brooks, D.J.7
Svendesen, C.N.8
Heywood, P.9
-
31
-
-
0028142644
-
Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl- 4- phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles
-
Gluck MR, Youngster SK, Ramsay RR, Singer TP, Nicklas WJ (1994) Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl- 4- phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles. J Neurochem 63: 655-661.
-
(1994)
J Neurochem
, vol.63
, pp. 655-661
-
-
Gluck, M.R.1
Youngster, S.K.2
Ramsay, R.R.3
Singer, T.P.4
Nicklas, W.J.5
-
32
-
-
0031939204
-
Protein nitration in Parkinson's disease
-
Good PF, Hsu A, Werner P, Perl DP, Olanow CW (1998) Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 57: 338-342.
-
(1998)
J Neuropathol Exp Neurol
, vol.57
, pp. 338-342
-
-
Good, P.F.1
Hsu, A.2
Werner, P.3
Perl, D.P.4
Olanow, C.W.5
-
33
-
-
0343550312
-
Apomorphine protects against MPTP-induced neurotoxicity in mice
-
Grunblatt E, Mandel S, Berkuzki T, Youdim MB (1999) Apomorphine protects against MPTP-induced neurotoxicity in mice. Mov Disord 14: 469-481.
-
(1999)
Mov Disord
, vol.14
, pp. 469-481
-
-
Grunblatt, E.1
Mandel, S.2
Berkuzki, T.3
Youdim, M.B.4
-
34
-
-
0033598713
-
Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
-
Ha HC, Snyder SH (1999) Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. PNAS 96: 13978-13982.
-
(1999)
PNAS
, vol.96
, pp. 13978-13982
-
-
Ha, H.C.1
Snyder, S.H.2
-
35
-
-
0025880072
-
Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine- treated mouse
-
Hadjiconstantinou M, Fitkin JG, Dalia A, Neff NH (1991) Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine- treated mouse. J Neurochem 57: 479-482.
-
(1991)
J Neurochem
, vol.57
, pp. 479-482
-
-
Hadjiconstantinou, M.1
Fitkin, J.G.2
Dalia, A.3
Neff, N.H.4
-
36
-
-
0029844003
-
Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
-
Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2: 1017-1021.
-
(1996)
Nat Med
, vol.2
, pp. 1017-1021
-
-
Hantraye, P.1
Brouillet, E.2
Ferrante, R.3
Palfi, S.4
Dolan, R.5
Matthews, R.T.6
Beal, M.F.7
-
37
-
-
0024997609
-
+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
-
+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170: 1049-1055.
-
(1990)
Biochem Biophys Res Commun
, vol.170
, pp. 1049-1055
-
-
Hasegawa, E.1
Takeshige, K.2
Oishi, T.3
Murai, Y.4
Minakami, S.5
-
38
-
-
0028239366
-
Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsiveeffect
-
Hayakawa T, Higuchi Y, Nigami H, Hattori H (1994) Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsiveeffect. Eur J Pharmacol 257: 131-136.
-
(1994)
Eur J Pharmacol
, vol.257
, pp. 131-136
-
-
Hayakawa, T.1
Higuchi, Y.2
Nigami, H.3
Hattori, H.4
-
39
-
-
0242384139
-
Ethanol effects on neonatal rat cortex: Comparative analyses of neurotrophic factors, apoptosis-related proteins, and oxidative processes during vulnerable and resistant periods
-
Heaton MB, Paiva M, Madorsky I, Shaw G (2003) Ethanol effects on neonatal rat cortex: comparative analyses of neurotrophic factors, apoptosis-related proteins, and oxidative processes during vulnerable and resistant periods. Brain Res Dev Brain Res 145: 249-262.
-
(2003)
Brain Res Dev Brain Res
, vol.145
, pp. 249-262
-
-
Heaton, M.B.1
Paiva, M.2
Madorsky, I.3
Shaw, G.4
-
40
-
-
0021280826
-
Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
-
Heikkila RE, Hess A, Duvoisin RC (1984a) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224: 1451-1453.
-
(1984)
Science
, vol.224
, pp. 1451-1453
-
-
Heikkila, R.E.1
Hess, A.2
Duvoisin, R.C.3
-
41
-
-
0021224694
-
Protection against the dopaminergic neurotox icity of 1-methyl-4-phenyl-1,2,3,6- tetrahydroxypyridine by monoamine oxidase inhibitors
-
Heikkila RE, Manzino L, Cabbat ES, Duvosion RC (1984b) Protection against the dopaminergic neurotox icity of 1-methyl-4-phenyl-1,2,3,6- tetrahydroxypyridine by monoamine oxidase inhibitors. Nature 311: 467-469.
-
(1984)
Nature
, vol.311
, pp. 467-469
-
-
Heikkila, R.E.1
Manzino, L.2
Cabbat, E.S.3
Duvosion, R.C.4
-
42
-
-
0031715925
-
Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration?
-
Hirsch EC, Hunot S, Damier P, Faucheux B (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol 44: 115-120.
-
(1998)
Ann Neurol
, vol.44
, pp. 115-120
-
-
Hirsch, E.C.1
Hunot, S.2
Damier, P.3
Faucheux, B.4
-
43
-
-
33846839625
-
No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes
-
Huerta C, Sanchez-Ferrero E, Coto E, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Alvarez V (2007) No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes. Neurosci Lett 413: 202-205.
-
(2007)
Neurosci Lett
, vol.413
, pp. 202-205
-
-
Huerta, C.1
Sanchez-Ferrero, E.2
Coto, E.3
Blazquez, M.4
Ribacoba, R.5
Guisasola, L.M.6
Salvador, C.7
Alvarez, V.8
-
44
-
-
0343844458
-
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
-
Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72: 355-363.
-
(1996)
Neuroscience
, vol.72
, pp. 355-363
-
-
Hunot, S.1
Boissiere, F.2
Faucheux, B.3
Brugg, B.4
Mouatt-Prigent, A.5
Agid, Y.6
Hirsch, E.C.7
-
45
-
-
0030842085
-
Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson's disease
-
Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson's disease. PNAS 94: 7531-7536.
-
(1997)
PNAS
, vol.94
, pp. 7531-7536
-
-
Hunot, S.1
Brugg, B.2
Ricard, D.3
Michel, P.P.4
Muriel, M.P.5
Ruberg, M.6
Faucheux, B.A.7
Agid, Y.8
Hirsch, E.C.9
-
46
-
-
0020382699
-
Pharmacokinetic studies of AD-810, a new antiepileptic compound. Phase I trials
-
Ito T, Yamaguchi T, Miyazaki H, Sekine Y, Shimizu M, Ishida S, Yagi K, Kakegawa N, Seino M, Wada T (1982) Pharmacokinetic studies of AD-810, a new antiepileptic compound. Phase I trials. Arzneimittelforschung 32: 1581-1586.
-
(1982)
Arzneimittelforschung
, vol.32
, pp. 1581-1586
-
-
Ito, T.1
Yamaguchi, T.2
Miyazaki, H.3
Sekine, Y.4
Shimizu, M.5
Ishida, S.6
Yagi, K.7
Kakegawa, N.8
Seino, M.9
Wada, T.10
-
47
-
-
2442638936
-
Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4- (3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
-
Iwashita A, Yamazaki S, Mihara K, Hattori K, Yamamoto H, Ishida J, Matsuoka N, Mutoh S (2004) Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4- (3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Pharmacol Exp Ther 309: 1067-1078.
-
(2004)
J Pharmacol Exp Ther
, vol.309
, pp. 1067-1078
-
-
Iwashita, A.1
Yamazaki, S.2
Mihara, K.3
Hattori, K.4
Yamamoto, H.5
Ishida, J.6
Matsuoka, N.7
Mutoh, S.8
-
48
-
-
0026342172
-
Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites
-
Johannessen JN, Sobotka TJ, Weise VK, Markey SP (1991) Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites. J Neurochem 57: 981-990.
-
(1991)
J Neurochem
, vol.57
, pp. 981-990
-
-
Johannessen, J.N.1
Sobotka, T.J.2
Weise, V.K.3
Markey, S.P.4
-
49
-
-
0033456249
-
Etodolac: An overview of a selective COX-2 inhibitor
-
Jones RA (1999) Etodolac: An overview of a selective COX-2 inhibitor. Inflammopharmacology 7:269-275.
-
(1999)
Inflammopharmacology
, vol.7
, pp. 269-275
-
-
Jones, R.A.1
-
50
-
-
61549143699
-
Age- and sexdifferences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine
-
Joniec I, Ciesielska A, Kurkowska I, Przybylkowski A, Czlonkowska A, Czlonkowski A (2009) Age- and sexdifferences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine. Brain Res 1261: 1362-1367.
-
(2009)
Brain Res
, vol.1261
, pp. 1362-1367
-
-
Joniec, I.1
Ciesielska, A.2
Kurkowska, I.3
Przybylkowski, A.4
Czlonkowska, A.5
Czlonkowski, A.6
-
51
-
-
3042654997
-
Does cellular iron dysregulation play a causative role in Parkinson's disease?
-
Kauer D, Andersen J (2004) Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev 3: 327-343.
-
(2004)
Ageing Res Rev
, vol.3
, pp. 327-343
-
-
Kauer, D.1
Andersen, J.2
-
52
-
-
0029869269
-
NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals
-
Kirschner PB, Jenkins BG, Schulz JB, Finkelstein SP, Matthews RT, Rosen BR, Beal MF (1996) NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Brain Res 713: 178-185.
-
(1996)
Brain Res
, vol.713
, pp. 178-185
-
-
Kirschner, P.B.1
Jenkins, B.G.2
Schulz, J.B.3
Finkelstein, S.P.4
Matthews, R.T.5
Rosen, B.R.6
Beal, M.F.7
-
53
-
-
77954085675
-
Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease
-
Kuroiwa H, Yokoyama H, Kimoto H, Kato H, Araki T (2010) Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease. Metab Brain Dis 25: 177-183.
-
(2010)
Metab Brain Dis
, vol.25
, pp. 177-183
-
-
Kuroiwa, H.1
Yokoyama, H.2
Kimoto, H.3
Kato, H.4
Araki, T.5
-
54
-
-
33846641782
-
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: Fenofibrate has a neuroprotective effect, whereas benzafibrate and HMG-CoA reductase inhibitors do not
-
Kreisler A, Gele P, Wiart JF, Lhermitte M, Destee A, Bordet R (2007) Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: Fenofibrate has a neuroprotective effect, whereas benzafibrate and HMG-CoA reductase inhibitors do not. Brain Res 1135: 77-84.
-
(2007)
Brain Res
, vol.1135
, pp. 77-84
-
-
Kreisler, A.1
Gele, P.2
Wiart, J.F.3
Lhermitte, M.4
Destee, A.5
Bordet, R.6
-
55
-
-
0030864433
-
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
-
Lan J, Jiang DH (1997) Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J Neural Transm 104: 469-481.
-
(1997)
J Neural Transm
, vol.104
, pp. 469-481
-
-
Lan, J.1
Jiang, D.H.2
-
56
-
-
33644833272
-
Randomized controlled trial of intraputamental glial cell line-derived neurotrophic factor infusion in Parkinson's disease
-
Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, Penn R, Brooks DJ, Hotton G, Moro E, Heywood P, Brodsky MA, Burchiel K, Kelly P, Dalvi A, Scott B, Stacy M, Tuner D, Wooten VG, Elias WJ, Elias WJ, Laws ER, Dhawan V, Stoessl AJ, Matcham J, Coffey RJ, Traub M (2006) Randomized controlled trial of intraputamental glial cell line-derived neurotrophic factor infusion in Parkinson's disease. Ann Neurol 59: 459-466.
-
(2006)
Ann Neurol
, vol.59
, pp. 459-466
-
-
Lang, A.E.1
Gill, S.2
Patel, N.K.3
Lozano, A.4
Nutt, J.G.5
Penn, R.6
Brooks, D.J.7
Hotton, G.8
Moro, E.9
Heywood, P.10
Brodsky, M.A.11
Burchiel, K.12
Kelly, P.13
Dalvi, A.14
Scott, B.15
Stacy, M.16
Tuner, D.17
Wooten, V.G.18
Elias, W.J.19
Elias, W.J.20
Laws, E.R.21
Dhawan, V.22
Stoessl, A.J.23
Matcham, J.24
Coffey, R.J.25
Traub, M.26
more..
-
57
-
-
0020680904
-
Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis
-
Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis. Science 219: 979-980.
-
(1983)
Science
, vol.219
, pp. 979-980
-
-
Langston, J.W.1
Ballard, P.2
Tetrud, J.W.3
Irwin, I.4
-
58
-
-
0021337873
-
Selective nigral toxicity after systemic administration of 1-methyl- 4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
-
Langston JW, Forno LS, Rebert CS, Irwin I (1984) Selective nigral toxicity after systemic administration of 1-methyl- 4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res 292: 390-394.
-
(1984)
Brain Res
, vol.292
, pp. 390-394
-
-
Langston, J.W.1
Forno, L.S.2
Rebert, C.S.3
Irwin, I.4
-
59
-
-
0032710609
-
Inducible nitric oxide synthase stimulates dopaminergic neurodegeration in the MPTP model of Parkinson disease
-
Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeration in the MPTP model of Parkinson disease. Nat Med 5: 1403-1409.
-
(1999)
Nat Med
, vol.5
, pp. 1403-1409
-
-
Liberatore, G.T.1
Jackson-Lewis, V.2
Vukosavic, S.3
Mandir, A.S.4
Vila, M.5
McAuliffe, W.G.6
Dawson, V.L.7
Dawson, T.M.8
Przedborski, S.9
-
60
-
-
33750347347
-
Mitochondrial dysfunction and oxidative stress in neurodegenerative disease
-
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative disease. Nature 443: 787-795.
-
(2006)
Nature
, vol.443
, pp. 787-795
-
-
Lin, M.T.1
Beal, M.F.2
-
61
-
-
0035983408
-
Parametric mapping of [18F]FPCT binding in early stage Parkinson's disease: A PET study
-
Ma Y, Dhawan V, Mentis M, Chaly T, Spetsiers PG, Eidelberg D (2002) Parametric mapping of [18F]FPCT binding in early stage Parkinson's disease: a PET study. Synapse 45: 125-133.
-
(2002)
Synapse
, vol.45
, pp. 125-133
-
-
Ma, Y.1
Dhawan, V.2
Mentis, M.3
Chaly, T.4
Spetsiers, P.G.5
Eidelberg, D.6
-
62
-
-
0023789193
-
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's disease and Alzheimer's disease brains
-
MacGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's disease and Alzheimer's disease brains. Neurology 38: 1285-1291.
-
(1988)
Neurology
, vol.38
, pp. 1285-1291
-
-
Macgeer, P.L.1
Itagaki, S.2
Boyes, B.E.3
McGeer, E.G.4
-
63
-
-
0034329823
-
NMDA but not non-NMDA excitotoxicity is mediated by poly (ADP-ribose) polymerase
-
Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, Feldman A, Poirier GG, Wang ZQ, Dawson TM, Dawson VL (2000) NMDA but not non-NMDA excitotoxicity is mediated by poly (ADP-ribose) polymerase. J Neurosci 20: 8005-8011.
-
(2000)
J Neurosci
, vol.20
, pp. 8005-8011
-
-
Mandir, A.S.1
Poitras, M.F.2
Berliner, A.R.3
Herring, W.J.4
Guastella, D.B.5
Feldman, A.6
Poirier, G.G.7
Wang, Z.Q.8
Dawson, T.M.9
Dawson, V.L.10
-
64
-
-
0021137683
-
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
-
Markey SP, Johannessen JN, Chiueh CC, Burns RS, Herkenham MA (1984) Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311: 464-467.
-
(1984)
Nature
, vol.311
, pp. 464-467
-
-
Markey, S.P.1
Johannessen, J.N.2
Chiueh, C.C.3
Burns, R.S.4
Herkenham, M.A.5
-
65
-
-
21144439005
-
Open-label adjunctive zonisamide in the treatment of bipolar disorders: A prospective trial
-
McElroy SL, Suppes T, Keck JrPE, Black D, Frye MA, Altshuler LL, Nolen WA, Kupka RW, Leverich GS, Walden J, Grunze H, Post RM (2005) Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J Clin Psychiatry 66: 617-624.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 617-624
-
-
McElroy, S.L.1
Suppes, T.2
Keck, J.3
Black, D.4
Frye, M.A.5
Altshuler, L.L.6
Nolen, W.A.7
Kupka, R.W.8
Leverich, G.S.9
Walden, J.10
Grunze, H.11
Post, R.M.12
-
66
-
-
0037227397
-
Altered proteasomal function in sporadic Parkinson's disease
-
McNaught KS, Belizaire P, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol 179: 38-46.
-
(2003)
Exp Neurol
, vol.179
, pp. 38-46
-
-
McNaught, K.S.1
Belizaire, P.2
Isacson, O.3
Jenner, P.4
Olanow, C.W.5
-
68
-
-
1442276965
-
Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease
-
Murata M (2004) Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease. Curr Pharm Des 10: 687-693.
-
(2004)
Curr Pharm Des
, vol.10
, pp. 687-693
-
-
Murata, M.1
-
69
-
-
33846054367
-
Zonisamide improves motor function in Parkinson's disease: A randomized, double-blind study
-
Murata M, Hasegawa K, Kanazawa I (2007) Zonisamide improves motor function in Parkinson's disease: a randomized, double-blind study. Neurology 68: 45-50.
-
(2007)
Neurology
, vol.68
, pp. 45-50
-
-
Murata, M.1
Hasegawa, K.2
Kanazawa, I.3
-
70
-
-
0034525420
-
Changes in cytokines and neurotrophins in Parkinson's disease
-
Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm 60: 277-290.
-
(2000)
J Neural Transm
, vol.60
, pp. 277-290
-
-
Nagatsu, T.1
Mogi, M.2
Ichinose, H.3
Togari, A.4
-
71
-
-
0035914209
-
GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons
-
Nakajima K, Hida H, Shimano Y, Fujimoto I, Hashitani T, Kumazaki M, Sakurai T, Nishino H (2001) GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res 916: 76-84.
-
(2001)
Brain Res
, vol.916
, pp. 76-84
-
-
Nakajima, K.1
Hida, H.2
Shimano, Y.3
Fujimoto, I.4
Hashitani, T.5
Kumazaki, M.6
Sakurai, T.7
Nishino, H.8
-
72
-
-
26444465185
-
L-DOPA treatment from the viewpoint of neuroprotection: Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease
-
Ogawa N, Asanuma M, Miyazaki I, Diaz-Corrales F, Miyoshi K (2005) L-DOPA treatment from the viewpoint of neuroprotection: possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease. J Neurol 252: iv23-iv31.
-
(2005)
J Neurol
, vol.252
-
-
Ogawa, N.1
Asanuma, M.2
Miyazaki, I.3
Diaz-Corrales, F.4
Miyoshi, K.5
-
73
-
-
0028430953
-
FGF-2 in the MPTP model of Parkinson's disease: Effects on astroglial cells
-
Otto D, Unsicker K (1994) FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells. Glia 11: 47-56.
-
(1994)
Glia
, vol.11
, pp. 47-56
-
-
Otto, D.1
Unsicker, K.2
-
74
-
-
0036157268
-
Inhibition of autoimmune encephalomyelitis by a tetracycline
-
Popovic N, Schubart A, Goetz BD, Zhang SC, Linington C, Duncan ID (2002) Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51: 215-223.
-
(2002)
Ann Neurol
, vol.51
, pp. 215-223
-
-
Popovic, N.1
Schubart, A.2
Goetz, B.D.3
Zhang, S.C.4
Linington, C.5
Duncan, I.D.6
-
75
-
-
0029984860
-
Role of neuronal nitric oxide in 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
-
Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. PNAS 93: 4565-4571.
-
(1996)
PNAS
, vol.93
, pp. 4565-4571
-
-
Przedborski, S.1
Jackson-Lewis, V.2
Yokoyama, R.3
Shibata, T.4
Dawson, V.L.5
Dawson, T.M.6
-
76
-
-
0037378689
-
Limitations of current Parkinson's disease therapy
-
Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL (2003) Limitations of current Parkinson's disease therapy. Ann Neurol 53: S3-S15.
-
(2003)
Ann Neurol
, vol.53
-
-
Rascol, O.1
Payoux, P.2
Ory, F.3
Ferreira, J.J.4
Brefel-Courbon, C.5
Montastruc, J.L.6
-
77
-
-
0023141542
-
Aging and 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra
-
Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW (1987) Aging and 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res 403: 43-51.
-
(1987)
Brain Res
, vol.403
, pp. 43-51
-
-
Ricaurte, G.A.1
Irwin, I.2
Forno, L.S.3
Delanney, L.E.4
Langston, E.5
Langston, J.W.6
-
78
-
-
0024593140
-
Blockade of sustained repetitive action potentials in cultured spin al cord neurons by zonisaimde (AD 810, CI 912), a novel anticonvulsant
-
Rock D, MacDonald R, Taylor C (1989) Blockade of sustained repetitive action potentials in cultured spin al cord neurons by zonisaimde (AD 810, CI 912), a novel anticonvulsant. Epilepsy Res 3: 138-143.
-
(1989)
Epilepsy Res
, vol.3
, pp. 138-143
-
-
Rock, D.1
Macdonald, R.2
Taylor, C.3
-
79
-
-
0033811469
-
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia
-
Schäbitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S (2000) Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 31: 2212-2217.
-
(2000)
Stroke
, vol.31
, pp. 2212-2217
-
-
Schäbitz, W.R.1
Sommer, C.2
Zoder, W.3
Kiessling, M.4
Schwaninger, M.5
Schwab, S.6
-
80
-
-
0023186374
-
Zonisamide enhances slow sodium inactivation in Myxicola
-
Schauf C (1987) Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res 413: 185-188.
-
(1987)
Brain Res
, vol.413
, pp. 185-188
-
-
Schauf, C.1
-
81
-
-
0028796770
-
Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice
-
Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64: 936-939.
-
(1995)
J Neurochem
, vol.64
, pp. 936-939
-
-
Schulz, J.B.1
Matthews, R.T.2
Muqit, M.M.3
Browne, S.E.4
Beal, M.F.5
-
82
-
-
0031978372
-
Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: Selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway
-
Skaper SD, Floreani M, Negro A, Facci L, Giusti P (1996) Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J Neurochem 70: 1859-1868.
-
(1996)
J Neurochem
, vol.70
, pp. 1859-1868
-
-
Skaper, S.D.1
Floreani, M.2
Negro, A.3
Facci, L.4
Giusti, P.5
-
83
-
-
0026689954
-
Brain-derived neuotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methy-4-phenylpyridinum ion toxicity: Involvement of the glutathione system
-
Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neuotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methy-4-phenylpyridinum ion toxicity: involvement of the glutathione system. J Neurochem 59: 99-106.
-
(1992)
J Neurochem
, vol.59
, pp. 99-106
-
-
Spina, M.B.1
Squinto, S.P.2
Miller, J.3
Lindsay, R.M.4
Hyman, C.5
-
84
-
-
0031036391
-
Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice
-
Sriram K, Pai KS, Boyd MR, Ravindranath V (1997) Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice. Brain Res 749: 44-52.
-
(1997)
Brain Res
, vol.749
, pp. 44-52
-
-
Sriram, K.1
Pai, K.S.2
Boyd, M.R.3
Ravindranath, V.4
-
85
-
-
33645123006
-
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: Role of tumor necrosis factor
-
Sriram K, Miller DB, O'Callaghan P (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor. J Neurochem 96: 706-718.
-
(2006)
J Neurochem
, vol.96
, pp. 706-718
-
-
Sriram, K.1
Miller, D.B.2
O'Callaghan, P.3
-
86
-
-
0026643459
-
Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex
-
Suzuki S, Kawakami K, Nishimura S, Watanabe Y, Yagi K, Seino M, Miyamoto K (1992) Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res 12: 21-27.
-
(1992)
Epilepsy Res
, vol.12
, pp. 21-27
-
-
Suzuki, S.1
Kawakami, K.2
Nishimura, S.3
Watanabe, Y.4
Yagi, K.5
Seino, M.6
Miyamoto, K.7
-
87
-
-
0032127666
-
Role of poly (ADP-ribose) synthetase in inflammation and ischemia-reperfusion
-
Szabo C, Dawson W (1998) Role of poly (ADP-ribose) synthetase in inflammation and ischemia-reperfusion. Trends Pharmacol Sci 19: 287-298.
-
(1998)
Trends Pharmacol Sci
, vol.19
, pp. 287-298
-
-
Szabo, C.1
Dawson, W.2
-
88
-
-
0035876916
-
Minocycline provides neuroprotection against N-methyl-D-aspirate neurotoxicity by inhibiting microglia
-
Tikka TM, Koistinaho JE (2001) Minocycline provides neuroprotection against N-methyl-D-aspirate neurotoxicity by inhibiting microglia. J Immunol 166: 7527-7533.
-
(2001)
J Immunol
, vol.166
, pp. 7527-7533
-
-
Tikka, T.M.1
Koistinaho, J.E.2
-
89
-
-
0027504297
-
Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds
-
Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61: 1191-1206.
-
(1993)
J Neurochem
, vol.61
, pp. 1191-1206
-
-
Tipton, K.F.1
Singer, T.P.2
-
90
-
-
0031723465
-
Enhanced poly (ADP-ribosyl)ation after focal ischemia in rat brain
-
Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K (1998) Enhanced poly (ADP-ribosyl)ation after focal ischemia in rat brain. J Cereb Blood Flow Metab 18: 991-997.
-
(1998)
J Cereb Blood Flow Metab
, vol.18
, pp. 991-997
-
-
Tokime, T.1
Nozaki, K.2
Sugino, T.3
Kikuchi, H.4
Hashimoto, N.5
Ueda, K.6
-
91
-
-
0029103262
-
Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine- induced parkinsonism in monkeys
-
Tsukahara T, Takeda M, Shimohama S, Ohara O, Hashimoto N (1995) Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine- induced parkinsonism in monkeys. Neurosurgery 37: 733-739.
-
(1995)
Neurosurgery
, vol.37
, pp. 733-739
-
-
Tsukahara, T.1
Takeda, M.2
Shimohama, S.3
Ohara, O.4
Hashimoto, N.5
-
92
-
-
0037713529
-
Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease
-
Wang H, Shimoj M, Yu SW, Dawson TM, Dawson VL (2003) Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann NY Acad Sci 991: 132-139.
-
(2003)
Ann NY Acad Sci
, vol.991
, pp. 132-139
-
-
Wang, H.1
Shimoj, M.2
Yu, S.W.3
Dawson, T.M.4
Dawson, V.L.5
-
93
-
-
0028292964
-
Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions
-
Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268: 1597-1604.
-
(1994)
J Pharmacol Exp Ther
, vol.268
, pp. 1597-1604
-
-
Watanabe, T.1
Yuki, S.2
Egawa, M.3
Nishi, H.4
-
94
-
-
0037785449
-
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
-
REAL-PET Study Group
-
Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ; REAL-PET Study Group (2003) Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol 54: 93-101.
-
(2003)
Ann Neurol
, vol.54
, pp. 93-101
-
-
Whone, A.L.1
Watts, R.L.2
Stoessl, A.J.3
Davis, M.4
Reske, S.5
Nahmias, C.6
Lang, A.E.7
Rascol, O.8
Ribeiro, M.J.9
Remy, P.10
Poewe, W.H.11
Hauser, R.A.12
Brooks, D.J.13
-
95
-
-
0141593395
-
Minocycline enhances MPTP toxicity to dopaminergic neurons
-
Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74: 278-285.
-
(2003)
J Neurosci Res
, vol.74
, pp. 278-285
-
-
Yang, L.1
Sugama, S.2
Chirichigno, J.W.3
Gregorio, J.4
Lorenzl, S.5
Shin, D.H.6
Browne, S.E.7
Shimizu, Y.8
Joh, T.H.9
Beal, M.F.10
Albers, D.S.11
-
96
-
-
74149085603
-
A novel anti-parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice
-
Yano R, Yokoyama H, Kuroiwa H, Kato H, Araki T (2009) A novel anti-parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice. J Mol Neurosci 39: 211-219.
-
(2009)
J Mol Neurosci
, vol.39
, pp. 211-219
-
-
Yano, R.1
Yokoyama, H.2
Kuroiwa, H.3
Kato, H.4
Araki, T.5
-
97
-
-
44949242548
-
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice
-
Yokoyama H, Takagi S, Watanabe Y, Kato H, Araki T (2008) Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. J Neural Transm 115: 831-842.
-
(2008)
J Neural Transm
, vol.115
, pp. 831-842
-
-
Yokoyama, H.1
Takagi, S.2
Watanabe, Y.3
Kato, H.4
Araki, T.5
-
98
-
-
77952038836
-
Poly (ADP-ribose) polymerase (PARP) nhibitor can attenuate the neuronal death after MPTP-induced neurotoxicity in mice
-
Yokoyama H, Kuroiwa H, Tsukada T, Uchida H, Kato H, Araki T (2010a) Poly (ADP-ribose) polymerase (PARP) nhibitor can attenuate the neuronal death after MPTP-induced neurotoxicity in mice. J Neurosci Res 88: 1522-1536.
-
(2010)
J Neurosci Res
, vol.88
, pp. 1522-1536
-
-
Yokoyama, H.1
Kuroiwa, H.2
Tsukada, T.3
Uchida, H.4
Kato, H.5
Araki, T.6
-
99
-
-
77954089281
-
Therapeutic effect of a novel ant-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice
-
Yokoyama H, Yano R, Kuroiwa H, Tsukada T, Uchida H, Kato H, Kasahara J, Araki T (2010b) Therapeutic effect of a novel ant-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Metab Brain Dis 25: 135-143.
-
(2010)
Metab Brain Dis
, vol.25
, pp. 135-143
-
-
Yokoyama, H.1
Yano, R.2
Kuroiwa, H.3
Tsukada, T.4
Uchida, H.5
Kato, H.6
Kasahara, J.7
Araki, T.8
-
100
-
-
0037067317
-
Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor
-
Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL (2002) Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263.
-
(2002)
Science
, vol.297
, pp. 259-263
-
-
Yu, S.W.1
Wang, H.2
Poitras, M.F.3
Coombs, C.4
Bowers, W.J.5
Federoff, H.J.6
Poirier, G.G.7
Dawson, T.M.8
Dawson, V.L.9
-
101
-
-
0028294246
-
Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity
-
Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689.
-
(1994)
Science
, vol.263
, pp. 687-689
-
-
Zhang, J.1
Dawson, V.L.2
Dawson, T.M.3
Snyder, S.H.4
|